Ipilimumab/nivolumabCardiogenic shock and myocarditis: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2020年 / 1792卷 / 1期

关键词：

D O I：

10.1007/s40278-020-75241-2

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：133 / 133

相关论文

共 50 条

[1] Ipilimumab/nivolumabCardiogenic-shock secondary to cardiomyopathy: case report
[J]. Reactions Weekly, 2022, 1930 (1) : 315 - 315
[2] Ipilimumab/nivolumabHepatitis and myocarditis: case report
[J]. Reactions Weekly, 2023, 1965 (1) : 257 - 257
[3] Ipilimumab/nivolumabMyositis and myocarditis: case report
[J]. Reactions Weekly, 2020, 1797 (1) : 150 - 150
[4] Ipilimumab/nivolumabFulminant myocarditis: case report
[J]. Reactions Weekly, 2017, 1682 (1) : 174 - 174
[5] Ipilimumab/nivolumabFatal myocarditis: case report
[J]. Reactions Weekly, 2021, 1885 (1) : 278 - 278
[6] Ipilimumab/nivolumabAutoimmune myocarditis: case report
[J]. Reactions Weekly, 2016, 1611 (1) : 109 - 109
[7] NivolumabCardiogenic shock and sinus arrest secondary to hypothyroidism: case report
[J]. Reactions Weekly, 2021, 1849 (1) : 346 - 346
[8] Ipilimumab/nivolumabAutoimmune lymphocytic myocarditis: case report
[J]. Reactions Weekly, 2018, 1720 (1) : 148 - 148
[9] Ipilimumab/nivolumabAcute myocarditis and myositis: case report
[J]. Reactions Weekly, 2017, 1654 (1) : 194 - 194
[10] Ipilimumab/nivolumabHepatitis and acute myocarditis: case report
[J]. Reactions Weekly, 2020, 1795 (1) : 162 - 162

← 1 2 3 4 5 →